Keywords: Hyperpolarized MR (Gas), Hyperpolarized MR (Gas), xenon-129, HyperCEST, chemical exchange, Noria, R3-Noria-methanesulfonate
Motivation: In the setting of molecular MRI, designing a contrast agent that can be applied in clinical studies and which offers high sensitivity poses a significant challenge.
Goal(s): We aimed to demonstrate a novel water-soluble R3-Noria-MeSO3H macrocycle as a viable supramolecular cage agent for 129Xe molecular imaging.
Approach: Hyperpolarized 129Xe chemical exchange saturation transfer MR imaging and spectroscopy were conducted in vitro using a 3.0T clinical MRI scanner.
Results: We demonstrated that R3-Noria-MeSO3H produces a superior HyperCEST effect and investigated its dependence on concentrations in various aqueous solutions.
Impact: The introduction of the novel R3-Noria-MeSO3H macrocycle for HP 129Xe HyperCEST imaging marks a critical milestone, establishing a new frontier in 129Xe molecular imaging with heightened sensitivity and potential for advancing clinical applications in diagnostic precision and therapeutic monitoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords